Clinical Trial
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma
- PMID: 348305
Item in Clipboard
Clinical Trial
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma
Cancer Treat Rep.
1978 Mar.
Abstract
Thirty-nine patients with stage IIIMO non-cell bronchogenic carcinoma (NOBC) were treated with combined modality therapy: radiation therapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, and procarbazine. The median survival for all patients treated was 9.6 months compared to 6.4 months for historical controls (P = 0.015). Patients who responded to the treatment program had a significantly longer survival (median, 15.2 months) compared to nonresponders and historical controls (P less than 0.005). It is concluded that combined modality therapy is moderately effective therapy in stage IIIMO NOBC.
Similar articles
-
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.Cancer Treat Rep. 1976 Sep;60(9):1225-30. Cancer Treat Rep. 1976. PMID: 189920
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.J Thorac Cardiovasc Surg. 1983 Aug;86(2):180-5. J Thorac Cardiovasc Surg. 1983. PMID: 6308356
-
"CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.Cancer Clin Trials. 1979 Winter;2(4):321-6. Cancer Clin Trials. 1979. PMID: 394868 Clinical Trial.
-
[Drug therapy in bronchial carcinoma].Schweiz Med Wochenschr. 1995 Jul 22;125(29):1396-405. Schweiz Med Wochenschr. 1995. PMID: 7545824 Review. German.
-
Combination chemotherapy and radiation therapy in lung cancer.Semin Oncol. 1994 Jun;21(3 Suppl 6):72-8. Semin Oncol. 1994. PMID: 8052877 Review.
Cited by
-
Comparison of survival in nonresected well differentiated and poorly differentiated adenocarcinoma of the lung.J Cancer Res Clin Oncol. 1980;97(1):71-9. doi: 10.1007/BF00411280. J Cancer Res Clin Oncol. 1980. PMID: 7400209 Free PMC article.